| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0004 |